Santen Pharmaceutical Co Ltd SNPHF
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $10.55
- Day Range
- $11.07–11.07
- 52-Week Range
- $8.53–11.07
- Bid/Ask
- $10.43 / $12.79
- Market Cap
- $3.94 Bil
- Volume/Avg
- 402 / 4,285
Key Statistics
- Price/Earnings (Normalized)
- 14.69
- Price/Sales
- 1.95
- Dividend Yield (Trailing)
- 1.94%
- Dividend Yield (Forward)
- 1.94%
- Total Yield
- 4.81%
Company Profile
Santen Pharmaceutical Co Ltd is a drug manufacturing company that focuses on ophthalmic products. The company reports two primary operating segments: prescription ophthalmic pharmaceuticals and other. The pharmaceuticals segment includes over-the-counter pharmaceuticals, while the other segment includes medical devices. The vast majority of Santen's revenue is derived from its prescription ophthalmic pharmaceuticals segment, which manufactures and distributes prescription and OTC pharmaceuticals. Most of Santen's sales are generated in Japan, followed by other Asian countries.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Stock Style Box
- Mid Core
- Total Number of Employees
- 3,744
- Website
- http://www.santen.co.jp
Comparables
Valuation
|
Metric
|
SNPHF
|
4554
|
4581
|
|---|---|---|---|
Price/Earnings (Normalized) | 14.69 | 11.86 | 27.83 |
Price/Book Value | 1.99 | 0.76 | 0.84 |
Price/Sales | 1.95 | 0.77 | 2.17 |
Price/Cash Flow | 10.07 | 4.65 | 14.48 |
Price/Earnings
SNPHF
4554
4581
Financial Strength
|
Metric
|
SNPHF
|
4554
|
4581
|
|---|---|---|---|
Quick Ratio | 2.00 | 0.55 | 4.20 |
Current Ratio | 2.54 | 1.24 | 5.16 |
Interest Coverage | 11.62 | 58.74 | 68.75 |
Quick Ratio
SNPHF
4554
4581
Profitability
|
Metric
|
SNPHF
|
4554
|
4581
|
|---|---|---|---|
Return on Assets (Normalized) | 7.91% | 4.98% | 2.57% |
Return on Equity (Normalized) | 11.17% | 10.16% | 3.09% |
Return on Invested Capital (Normalized) | 9.63% | 6.17% | 2.64% |
Return on Assets
SNPHF
4554
4581
Drug Manufacturers - General Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Eli Lilly and Co
LLY
| Lpjpvltztg | Vbr | $724.5 Bil | |||
| Johnson & Johnson
JNJ
| Lcgdgjz | Ndk | $386.7 Bil | |||
| AbbVie Inc
ABBV
| Ccccqgzt | Nmkj | $327.0 Bil | |||
| Merck & Co Inc
MRK
| Qdgfrygx | Ntv | $317.3 Bil | |||
| Roche Holding AG ADR
RHHBY
| Twbkfvtrxw | Whxtv | $261.9 Bil | |||
| AstraZeneca PLC ADR
AZN
| Vtyfyktt | Jjbw | $242.7 Bil | |||
| Novartis AG ADR
NVS
| Fbxkbkdg | Cwcn | $224.0 Bil | |||
| Amgen Inc
AMGN
| Lzpswrlcp | Zzdtj | $179.6 Bil | |||
| Pfizer Inc
PFE
| Qdnzvgr | Mps | $174.4 Bil | |||
| Sanofi SA ADR
SNY
| Jtxykccm | Djwwr | $131.7 Bil |